Nutrition Outreach and Understanding: Research In Serving Hearts Through Healthy Eating And Tailored Support

Obesity Clinical Trial

— NOURISH HEARTS  

Official title:

NOURISH HEARTS: Nutrition Outreach and Understanding: Research In Serving Hearts Through Healthy Eating And Tailored Support

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06460272
• Other study ID #: 24-472
• Status: Not yet recruiting
• Phase: N/A
• Start date: June 19, 2024
• Est. completion date: December 19, 2025

Study information

• Verified date: June 2024
• Source: The Cleveland Clinic
• Contact: Narissa McCarty
• Phone: 2167801931
• Email: mccartn3[@]ccf.org
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study is a human-centered, three-arm, parallel-group, randomized control, implementation trial (n=75) to compare MTM (Medically Tailored Meals) only (14 meals delivered weekly for 10 weeks) vs. MTM + SMA (Shared Medical Appointments; once weekly sessions for 10 weeks) vs. a wait-list control group (MTM-Later) in patients with hypertension, type 2 diabetes, obesity, and/or metabolic syndrome. All intervention components will be culturally congruent (e.g., MTMs will include food that converges with culturally relevant diets and SMAs will be delivered by individuals with racial concordance to the target community). Primary outcomes will be implementation (recruitment and retention rates) and feasibility (engagement and satisfaction). Participants will be recruited from Cleveland Clinic's South Pointe Hospital in Warrensville Heights, a predominantly Black community with low socioeconomic status and high cardiovascular disease morbidity.

Description:

Subjects will be randomized into one of the three arms within the study: Medically Tailored Meals (MTMs): Collaborative agreements are in place with Performance Kitchen to prepare 2 meals/day for 7 days/week for 10 weeks at a discount for all participants (n =75) for this trial. Meals will be prepared based on evidence-based nutritional recommendations for the Mediterranean diet and that align with 2021 American Heart Association Dietary Guidance. Meals will be culturally tailored using methods used in the investigator's published pilot trial as well as data from other studies that have optimized cultural relevance of the Mediterranean diet for Black communities (e.g., meals that incorporate traditional staple foods). Individuals randomized to MTMs will receive electronic educational materials from the MTM + SMA group after the completion of the post-intervention study assessment. Medically Tailored Meals + Shared Medical Appointments (MTMs + SMAs): Identical MTMs that are provided in the MTM only group will also be provided in the MTM + SMA group. The SMA will be delivered weekly for 10 weeks and will be modeled after the investigator's pilot study. This includes practice with behavior change principles (i.e., selection of healthy food options). Thus, participants will be directed to access South Pointe Hospital's bi-monthly fresh produce pantry, where fresh produce will be guaranteed and available to them for pick-up. The provider, dietician, chef, and health coach will be members of the Black community to ensure racial concordance between educators and participants, a critical feature that improves communication, trust, and health outcomes in behavioral health interventions. The provider, dietician, and health coach are professionals currently employed within the Department of Wellness and Preventive Medicine. Fidelity will be ensured by using a session fidelity checklist that will be completed by each facilitator. To maximize retention, during consent via (telephone or in-person the study coordinator will establish rapport and set study expectations, including what SMAs entail and the time commitment for the session to minimize attrition. SMA visit reminder emails will be sent to participants through their EHR portal and/or via email. Medically Tailored Meals - Later (MTM-Later): The inclusion of a MTM-Later arm will provide a rigorous test of outcomes and is necessary given limited data about MTM implementation, engagement, and clinical outcomes in Black, underserved communities. MTM-Later participants will receive MTMs (same quantity and frequency) as the two other groups after the completion of the post-intervention study assessment. To avoid differential drop-out and incomplete assessments in the MTM-Later group, this group will be offered culinary tools at the start of the intervention to build trust and confidence that they will indeed receive the meals and educational materials at the end of the study assessment period. This group will act as the Waitlist Control group. All groups will receive a set of surveys to be given at baseline and weeks 5 and 10 for exploratory outcomes. All groups will also have labs drawn at baseline and week 10 to measure secondary outcomes such as change in HbA1c. 4 focus groups will also be conducted (2 groups from each treatment arm) to understand barriers and facilitators to engaging in each of the active treatments.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 75
• Est. completion date: December 19, 2025
• Est. primary completion date: December 19, 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Self-identification as Black or African American

2. Ability to speak and read English

3. Age = 18 years old

4. Diagnosis of any of the following: a) Hypertension (>130/80), and ever treated for hypertension; b) Type 2 Diabetes Mellitus (HgbA1c = 8%); c) Metabolic Syndrome; d) Obesity (BMI = 30)

5. Access to a web-enabled device (phone, tablet, computer)

6. Received care at Cleveland Clinic South Pointe Hospital within the past 6 months

Exclusion Criteria:

1. Pre-hypertension

2. Stage C and D heart failure

3. Advanced valvular heart disease

4. Advanced heart failure class D defined as heart failure symptoms impairing daily quality of life and/or resulting in recurrent hospitalizations (>1) per previous 12 months

5. Insulin requiring type II diabetes mellitus

6. Type I diabetes mellitus

7. Advanced chronic kidney disease (= Stage 4)

8. Severe obesity (Grade III or above) as defined by BMI > 40 kg/m2

9. Patients who are in another study or nutritional support program supplying meals

10. Advanced co-morbidity with diminished life expectancy < 2 years

11. Co-morbidity requiring immunosuppressive, immunotherapy, chemotherapy, chronic antibiotic therapy

12. Inability to participate in the demands and requirements of the trial

13. Significant cognitive impairment

Related Conditions & MeSH terms

• Diabetes Mellitus, Type 2
• Hypertension
• Metabolic Syndrome
• Obesity

Intervention

Other:
• Medically Tailored Meals
Meals culturally tailored to provide essential nutrition

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Amanda Shallcross	American Heart Association

References & Publications (32)

ASA24 Dietary Assessment Tool- EGRP/DCCPS/NCI/NIH. Accessed October 23, 2023. https://epi.grants.cancer.gov/asa24/

Attkisson CC, Zwick R. The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann. 1982;5(3):233-7. doi: 10.1016/0149-7189(82)90074-x. — View Citation

Belak L, Owens C, Smith M, Calloway E, Samnadda L, Egwuogu H, Schmidt S. The impact of medically tailored meals and nutrition therapy on biometric and dietary outcomes among food-insecure patients with congestive heart failure: a matched cohort study. BMC Nutr. 2022 Oct 3;8(1):108. doi: 10.1186/s40795-022-00602-y. — View Citation

Benjamins MR, Silva A, Saiyed NS, De Maio FG. Comparison of All-Cause Mortality Rates and Inequities Between Black and White Populations Across the 30 Most Populous US Cities. JAMA Netw Open. 2021 Jan 4;4(1):e2032086. doi: 10.1001/jamanetworkopen.2020.32086. — View Citation

Berkowitz SA, Delahanty LM, Terranova J, Steiner B, Ruazol MP, Singh R, Shahid NN, Wexler DJ. Medically Tailored Meal Delivery for Diabetes Patients with Food Insecurity: a Randomized Cross-over Trial. J Gen Intern Med. 2019 Mar;34(3):396-404. doi: 10.1007/s11606-018-4716-z. Epub 2018 Nov 12. — View Citation

Berkowitz SA, Shahid NN, Terranova J, Steiner B, Ruazol MP, Singh R, Delahanty LM, Wexler DJ. "I was able to eat what I am supposed to eat"-- patient reflections on a medically-tailored meal intervention: a qualitative analysis. BMC Endocr Disord. 2020 Jan 20;20(1):10. doi: 10.1186/s12902-020-0491-z. — View Citation

Bharmal N, Beidelschies M, Alejandro-Rodriguez M, Alejandro K, Guo N, Jones T, Bradley E. A nutrition and lifestyle-focused shared medical appointment in a resource-challenged community setting: a mixed-methods study. BMC Public Health. 2022 Mar 7;22(1):447. doi: 10.1186/s12889-022-12833-6. — View Citation

Black/African American Health-Office of Minority Health. Accessed October 24, 2023. https://minorityhealth.hhs.gov/blackafrican-american-health

Blumberg SJ, Bialostosky K, Hamilton WL, Briefel RR. The effectiveness of a short form of the Household Food Security Scale. Am J Public Health. 1999 Aug;89(8):1231-4. doi: 10.2105/ajph.89.8.1231. — View Citation

Chen, G., Gully, S.M., & Eden, D. (2001). Validation of a new general self-efficacy scale. Organizational Research Methods, 4(1), 62-83

Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available. — View Citation

Cohen, S., Memelstein, R., Kamarck, T., & Hoberman, H. (1985). Measuring the functional components of social support. In I.G. Sarason & B. Sarason (Eds.), Social support: Theory, research and application (pp.73-94). The Hague: Martinus Nijhoff

Diamond JJ. Development of a reliable and construct valid measure of nutritional literacy in adults. Nutr J. 2007 Feb 14;6:5. doi: 10.1186/1475-2891-6-5. — View Citation

Eisenhauer E. In poor health: Supermarket redlining and urban nutrition. GeoJournal. 2001;53(2):125-133. doi:10.1023/A:1015772503007

FastStats- Leading Causes of Death. Centers for Disease Control and Prevention. Published January 18, 2023. Accessed October 24, 2023. https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm

Feng YS, Kohlmann T, Janssen MF, Buchholz I. Psychometric properties of the EQ-5D-5L: a systematic review of the literature. Qual Life Res. 2021 Mar;30(3):647-673. doi: 10.1007/s11136-020-02688-y. Epub 2020 Dec 7. — View Citation

Fernander AF, Duran RE, Saab PG, Llabre MM, Schneiderman N. Assessing the reliability and validity of the John Henry Active Coping Scale in an urban sample of African Americans and white Americans. Ethn Health. 2003 May;8(2):147-61. doi: 10.1080/13557850303563. — View Citation

Gaglio B, Henton M, Barbeau A, Evans E, Hickam D, Newhouse R, Zickmund S. Methodological standards for qualitative and mixed methods patient centered outcomes research. BMJ. 2020 Dec 23;371:m4435. doi: 10.1136/bmj.m4435. — View Citation

Gardiner P, McGonigal L, Villa A, Kovell LC, Rohela P, Cauley A, Rinker D, Olendzki B. Our Whole Lives for Hypertension and Cardiac Risk Factors-Combining a Teaching Kitchen Group Visit With a Web-Based Platform: Feasibility Trial. JMIR Form Res. 2022 May 16;6(5):e29227. doi: 10.2196/29227. — View Citation

Hager K, Cudhea FP, Wong JB, Berkowitz SA, Downer S, Lauren BN, Mozaffarian D. Association of National Expansion of Insurance Coverage of Medically Tailored Meals With Estimated Hospitalizations and Health Care Expenditures in the US. JAMA Netw Open. 2022 Oct 3;5(10):e2236898. doi: 10.1001/jamanetworkopen.2022.36898. — View Citation

Hays RD, Spritzer KL, Schalet BD, Cella D. PROMIS(R)-29 v2.0 profile physical and mental health summary scores. Qual Life Res. 2018 Jul;27(7):1885-1891. doi: 10.1007/s11136-018-1842-3. Epub 2018 Mar 22. — View Citation

Lara-Breitinger KM, Medina Inojosa JR, Li Z, Kunzova S, Lerman A, Kopecky SL, Lopez-Jimenez F. Validation of a Brief Dietary Questionnaire for Use in Clinical Practice: Mini-EAT (Eating Assessment Tool). J Am Heart Assoc. 2023 Jan 3;12(1):e025064. doi: 10.1161/JAHA.121.025064. Epub 2022 Dec 30. — View Citation

Lichtenstein AH, Appel LJ, Vadiveloo M, Hu FB, Kris-Etherton PM, Rebholz CM, Sacks FM, Thorndike AN, Van Horn L, Wylie-Rosett J. 2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association. Circulation. 2021 Dec 7;144(23):e472-e487. doi: 10.1161/CIR.0000000000001031. Epub 2021 Nov 2. — View Citation

Medication History for Ambulatory-Surescripts. Accessed October 23, 2023. https://surescripts.com/what-we-do/medication-history-for-ambulatory

Moore C, Coates E, Watson A, de Heer R, McLeod A, Prudhomme A. "It's Important to Work with People that Look Like Me": Black Patients' Preferences for Patient-Provider Race Concordance. J Racial Ethn Health Disparities. 2023 Oct;10(5):2552-2564. doi: 10.1007/s40615-022-01435-y. Epub 2022 Nov 7. Erratum In: J Racial Ethn Health Disparities. 2023 Oct;10(5):2614. doi: 10.1007/s40615-022-01489-y. — View Citation

Prescription Prices, Coupons & Pharmacy Information. GoodRx. Accessed October 23, 2023. https://www.goodrx.com/

Research methods: Is restricted randomisation necessary? Accessed June 1, 2021. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1482349/

Rohela P, Olendzki B, McGonigal LJ, Villa A, Gardiner P. A Teaching Kitchen Medical Groups Visit with an eHealth Platform for Hypertension and Cardiac Risk Factors: A Qualitative Feasibility Study. J Altern Complement Med. 2021 Nov;27(11):974-983. doi: 10.1089/acm.2021.0148. Epub 2021 Aug 5. — View Citation

Satia JA. Diet-related disparities: understanding the problem and accelerating solutions. J Am Diet Assoc. 2009 Apr;109(4):610-5. doi: 10.1016/j.jada.2008.12.019. No abstract available. — View Citation

Sim J, Lewis M. The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency. J Clin Epidemiol. 2012 Mar;65(3):301-8. doi: 10.1016/j.jclinepi.2011.07.011. Epub 2011 Dec 9. — View Citation

Winham DM. Culturally tailored foods and CVD prevention. Am J Lifestyle Med. 2009;3(1):64S-68S. doi: 10.1177/1559827609335552. — View Citation

Woodward EN, Matthieu MM, Uchendu US, Rogal S, Kirchner JE. The health equity implementation framework: proposal and preliminary study of hepatitis C virus treatment. Implement Sci. 2019 Mar 12;14(1):26. doi: 10.1186/s13012-019-0861-y. — View Citation

* Note: There are 32 references in all — Click here to view all references

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Qualitative characterization of participants' lived experiences and engagement	4 focus groups (n=5 in each group, 2 groups from each treatment arm - MTM and MTM + SMA) will be conducted to understand barriers and facilitators to engaging in each of the active treatments.	Week 10
Primary	Recruitment Rate	Recruitment is a measure of treatment implementation. Recruitment rate will be measured by # of participants enrolled in study/# passed eligibility screening.	Baseline through Week 10
Primary	Retention Rate	Retention is a measure of treatment implementation. Retention rate will be measured by # of completed assessments at week 10/# randomized to treatment arm.	Baseline through Week 10
Primary	SMA Attendance	Engagement will be assessed by Shared Medical Appointment (SMA) session attendance over the 10 week period.	Baseline through Week 10
Primary	MTMs Consumed	Engagement will be assessed by proportion of Medically Tailored Meals (MTMs) consumed.	Baseline through Week 10
Primary	Satisfaction of the Intervention	Satisfaction of MTM vs. MTM + SMA will be assessed using the Net Promoter Score (scale of 0 to 10; 9-10 being promoters, 7-8 being passives, and 0-6 being detractors)	Baseline through Week 10
Secondary	Eating Behavior	Changes in eating behavior will be measured using the Mini-EAT (Eating Assessment Tool) and Fast Food/Restaurant Frequency Questionnaires.	Baseline and Week 10
Secondary	Body Weight	Body weight will be measured in pounds.	Baseline and Week 10
Secondary	Waist/Hip Circumference	Waist/Hip circumference will be expressed as a ratio.	Baseline and Week 10
Secondary	Systolic and Diastolic Blood Pressure (mmHg)	Systolic and diastolic blood pressure will be measured and expressed as mmHg.	Baseline and Week 10
Secondary	Hemoglobin A1c (HbA1c, mmol/mol)	Hemoglobin A1c will be evaluated through peripheral blood draw to assess diabetes control.	Baseline and Week 10
Secondary	Trimethylamine N-oxide (TMAO, uM)	Trimethylamine N-oxide will be evaluated through peripheral blood draw to assess cardiovascular disease risk.	Baseline and Week 10
Secondary	Uric Acid (mg/dL)	Uric Acid will be evaluated through peripheral blood draw to assess cardiovascular disease and diabetes risk.	Baseline and Week 10
Secondary	Vitamin D 25 Hydroxy (ng/mL)	Vitamin D 25 Hydroxy will be evaluated through peripheral blood draw to asses for Vitamin D deficiency.	Baseline and Week 10
Secondary	High Sensitivity C-Reactive Protein (hsCRP, mg/dL)	High Sensitivity C-Reactive Protein will be evaluated through peripheral blood draw to assess inflammation.	Baseline and Week 10